Serum Vitamin D Status and Breast Cancer Risk by Receptor Status: A Systematic Review.

Related Articles

Serum Vitamin D Status and Breast Cancer Risk by Receptor Status: A Systematic Review.

Nutr Cancer. 2018 May 21;:1-17

Authors: Tommie JL, Pinney SM, Nommsen-Rivers LA

Abstract
BACKGROUND: The association between vitamin D status and breast cancer risk is equivocal. No systematic reviews or meta-analyses have examined this association stratified by receptor status. Our objective is to conduct a systematic review to answer the question, "Is there a relationship between lower serum/plasma vitamin D levels and increased risk of triple negative breast cancer (TNBC) specifically?"
METHODS: We systematically searched Embase and PubMed databases for published original research studies examining the risk of a breast cancer diagnosis according to vitamin D status. We excluded studies that did not provide risk estimates stratified by receptor status.
RESULTS: Fourteen studies met our criteria, including case-control, nested case-control, and case-series studies, reflecting the cumulative results of 13,135 breast cancer cases. When grouped by relevancy to TNBC, the proportion of analyses across all study types showing a significant association between vitamin D status and breast cancer diagnosis was 37% for non-TNBC analyses, 48% for analyses that included some TNBC cases, and 88% for TNBC analyses.
CONCLUSIONS: Our results suggest that low vitamin D status may particularly increase the risk of TNBC, although more research is needed to determine if this association is causative. Women should be routinely screened for 25(OH)D deficiency.

PMID: 29781719 [PubMed - as supplied by publisher]

https://ift.tt/2GH1b0u